Barclays’s EMULEX CORP ELX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-791,734
Closed -$5.54M 7478
2015
Q1
$5.54M Buy
791,734
+761,606
+2,528% +$5.34M 0.01% 1487
2014
Q4
$150K Sell
30,128
-45,692
-60% -$246K ﹤0.01% 4868
2014
Q3
$302K Buy
75,820
+36,707
+94% +$199K ﹤0.01% 4390
2014
Q2
$195K Buy
39,113
+16,918
+76% +$101K ﹤0.01% 4843
2014
Q1
$155K Sell
22,195
-632,362
-97% -$4.65M ﹤0.01% 5043
2013
Q4
$4.58M Buy
654,557
+456,217
+230% +$3.39M ﹤0.01% 1905
2013
Q3
$1.39M Buy
198,340
+53,800
+37% +$418K ﹤0.01% 2983
2013
Q2
$942K Buy
+144,540
New +$909K ﹤0.01% 3453

Barclays's ELX Position: Q2 2015 in Review

Barclays sold out of EMULEX CORP (ELX) in Q2 2015, closing a stake of 791,734 shares — an estimated $5.54M sold.

Barclays first reported a position in ELX in Q2 2013 and held it in 8 quarters. The position peaked at $5.54M in Q1 2015. 0 funds tracked by Wall St. Rank hold ELX as of Q2 2015.

  • Barclays reported no remaining EMULEX CORP position as of Q2 2015 after selling out during the quarter.
  • Barclays sold 791,734 EMULEX CORP shares in Q2 2015, an estimated $5.54M.
  • Barclays first reported a position in EMULEX CORP in Q2 2013 and held it in 8 quarters.
  • Barclays's EMULEX CORP position peaked at $5.54M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held EMULEX CORP as of Q2 2015.

Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.